NASDAQ:BRLI - Bio-Reference Laboratories Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bio-Reference Laboratories, Inc. is a clinical testing laboratory, which offers testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a range of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It is focused on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional health care. It offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology and other tissue analysis. It operates a clinical knowledge management service through its PSIMedica business unit. It also operates a Web-based connectivity portal solution for laboratories and physicians through its CareEvolve subsidiary. Its laboratory testing business consists of routine testing and esoteric testing. Receive BRLI News and Ratings via Email Sign-up to receive the latest news and ratings for BRLI and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryHealth Care Services SectorN/A Current SymbolNASDAQ:BRLI Previous Symbol CUSIP09057G60 CIK792641 Webhttp://www.bioreference.com/ Phone+1-201-7912186Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Bio-Reference Laboratories (NASDAQ:BRLI) Frequently Asked Questions What is Bio-Reference Laboratories' stock symbol? Bio-Reference Laboratories trades on the NASDAQ under the ticker symbol "BRLI." How were Bio-Reference Laboratories' earnings last quarter? Bio-Reference Laboratories Inc (NASDAQ:BRLI) announced its quarterly earnings data on Thursday, December, 18th. The medical research company reported $0.66 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.63 by $0.03. The medical research company earned $227.60 million during the quarter, compared to analysts' expectations of $228.81 million. Bio-Reference Laboratories's revenue for the quarter was up 18.4% on a year-over-year basis. During the same period last year, the company posted $0.40 EPS. View Bio-Reference Laboratories' Earnings History. Has Bio-Reference Laboratories been receiving favorable news coverage? Headlines about BRLI stock have trended neutral on Friday, InfoTrie reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bio-Reference Laboratories earned a daily sentiment score of 0.3 on InfoTrie's scale. They also assigned news articles about the medical research company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near future. What other stocks do shareholders of Bio-Reference Laboratories own? Based on aggregate information from My MarketBeat watchlists, some companies that other Bio-Reference Laboratories investors own include Opko Health (OPK), Anacor Pharmaceuticals (ANAC), Gentex (GNTX), Halozyme Therapeutics (HALO), Nektar Therapeutics (NKTR), Rackspace Hosting (RAX), ACADIA Pharmaceuticals (ACAD), Agios Pharmaceuticals (AGIO), Alnylam Pharmaceuticals (ALNY) and Ambarella (AMBA). How do I buy shares of Bio-Reference Laboratories? Shares of BRLI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Bio-Reference Laboratories' official website? The official website for Bio-Reference Laboratories is http://www.bioreference.com/. How can I contact Bio-Reference Laboratories? Bio-Reference Laboratories' mailing address is 481 Edward H Ross Dr, ELMWOOD PARK, NJ 07407-3118, United States. The medical research company can be reached via phone at +1-201-7912186. MarketBeat Community Rating for Bio-Reference Laboratories (NASDAQ BRLI)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 96 (Vote Outperform)Underperform Votes: 89 (Vote Underperform)Total Votes: 185MarketBeat's community ratings are surveys of what our community members think about Bio-Reference Laboratories and other stocks. Vote "Outperform" if you believe BRLI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRLI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/24/2019 by MarketBeat.com StaffFeatured Article: Does the discount rate affect the economy? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.